Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system

BACKGROUND: In treatment-refractory liver dominant metastatic colorectal cancer, the role of liver directed therapies still is unclear. We sought to determine a prognostic score for Y90 radioembolization in these patients. METHODS: We analyzed 106 patients with refractory liver dominant mCRC who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Damm, Robert, Seidensticker, Ricarda, Ulrich, Gerhard, Breier, Leonie, Steffen, Ingo G., Seidensticker, Max, Garlipp, Benjamin, Mohnike, Konrad, Pech, Maciej, Amthauer, Holger, Ricke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955133/
https://www.ncbi.nlm.nih.gov/pubmed/27439702
http://dx.doi.org/10.1186/s12885-016-2549-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955133/
https://www.ncbi.nlm.nih.gov/pubmed/27439702
http://dx.doi.org/10.1186/s12885-016-2549-x

Ejemplares similares